Masimo Taps Katie Szyman
Masimo named Becton Dickinson executive Katie Szyman as its top boss, the medical device maker said on Tuesday, months after longtime CEO and founder Joe Kiani was ousted in a bitter proxy battle with ...
Today the Board of Directors (the “Board”) of Masimo (NASDAQ: MASI), a leading global medical innovator, announced that Katie Szyman has been appointe ...
Masimo (NASDAQ:MASI) is recognized for its innovative monitoring technologies, including measurements, sensors, patient ...
Masimo (NASDAQ:MASI – Get Free Report)‘s stock had its “hold” rating reaffirmed by equities research analysts at Needham & Company LLC in a research report issued on Wednesday,Benzinga reports.
Piper Sandler analyst Jason Bednar maintained a Buy rating on Masimo (MASI – Research Report) today and set a price target of $210.00. The ...
MASI's revenue growth in the fourth quarter is likely to have been boosted by the continued robust adoption of its products.
Additional information about Masimo and its products may be found at www.masimo.com. RPVi has not received FDA 510(k) clearance and is not available for sale in the United States. The use of the ...
markets sells and licenses premium and luxury audio sound products and related integration technologies. Financial Insights: Masimo Market Capitalization Analysis: Below industry benchmarks ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback